查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1493329

美國臉部注射劑市場規模、佔有率和趨勢分析報告：按產品、按應用、按最終用途、按地區和細分市場預測，2024-2030 年

U.S. Facial Injectable Market Size, Share & Trends Analysis Report By Product (Botulinum Toxin Type A, HA), By Application (Facial Line Correction, Lip Augmentation), By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 70 Pages | 商品交期: 2-10個工作天內

價格

美國臉部注射劑市場成長與趨勢：

根據Grand View Research, Inc.的最新報告，預計2030年美國臉部注射劑市場將達到80.2億美元，2024年至2030年的複合年成長率為11.1%。

對美容治療的接受度不斷提高以及老年人口的增加是推動市場成長的主要因素。

美國日益老化的人口正在增加對微創外科手術開發的需求。臉部注射劑提供了一些整容手術的替代方案。此外，這些手術還具有多種好處，例如減少疼痛、減少創傷、減少出血和恢復更快。此外，越來越多的市場參與者專注於開拓低過敏風險需求的專業解決方案，這對市場成長做出了重大貢獻。

由於對臉部外觀的日益關注，人們對整容手術的認知不斷提高，這進一步推動了市場的成長。此外，臉部注射劑的可用性可以滿足不同患者的需求，這增加了不同年齡層的需求，這取決於患者的需求。例如，根據美國整形外科醫師協會發布的2022年整形外科統計報告，2022年30-39歲和40-54歲年齡層的神經調節劑注射手術數量較2019年分別增加了70%和74%。同樣，到2022年，30-39歲和40-54歲年齡層的HA填充手術數量將比2019年同時增加69%和70%。因此，不同年齡層對臉部填充劑的需求不斷增加預計將在預測期內推動市場成長。

美國臉部注射劑市場報告亮點

  • A型肉毒桿菌毒素可以治療皺紋、魚尾紋、嘴角等多種病症，因此在2023年贏得了超過55%的市場佔有率，並在產品類型中佔據主導地位。
  • 由於越來越多的市場參與者專注於開發透明質酸填充劑，預計透明質酸細分市場將在預測期內實現最快的成長。對微創手術的需求不斷成長和整容手術的激增正在推動市場成長。
  • 在美國臉部填充劑市場運作的市場參與者包括AbbVie, Inc.、REVANCE AESTHETICS、Merz North America, Inc.、Galderma Laboratories, LP、Suneva Medical Inc.、Cytophil, Inc.、Prollenium Medical Technologies等。
  • 2023年5月，Evolus宣布與Cimatese簽訂了五種正在開發的真皮填充劑的經銷協議。這項舉措極大地幫助公司擴大了產品系列，並向成為多產品美容公司邁出了一步。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第3章美國臉部注射劑市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場推動要素分析
    • 市場限制因素分析
  • 美國臉部注射劑市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章美國臉部注射劑市場：產品預估及趨勢分析

  • 2023年及2030年產品市場佔有率
  • 細分儀表板
  • 美國臉部注射劑市場展望（分產品）
  • 2018-2030年市場規模、預測及趨勢分析
  • 膠原蛋白
  • A型肉毒桿菌毒素
  • HA
  • CaHA
  • PLLA
  • 其他

第5章美國臉部注射劑市場：應用預估及趨勢分析

  • 2023年及2030年應用市場佔有率
  • 細分儀表板
  • 美國臉部注射劑市場展望（按應用）
  • 2018-2030年市場規模、預測及趨勢分析
  • 輪廓矯正
  • 豐唇術
  • 拉皮
  • 痤瘡疤痕治療
  • 脂肪萎縮治療
  • 其他

第6章美國臉部注射劑市場：最終用途估計與趨勢分析

  • 2023 年及 2030 年最終用途市場佔有率
  • 細分儀表板
  • 按最終用途分類的美國臉部注射劑市場前景
  • 2018-2030年市場規模、預測及趨勢分析
  • 梅迪斯帕
  • 皮膚科診所
  • 醫院

第7章美國臉部注射劑市場：區域估計與趨勢分析

  • 2023 年和 2030 年按地區分類的市場佔有率佔有率
  • 美國臉部注射劑市場按地區前景
  • 2018-2030年市場規模、預測及趨勢分析
  • 西
  • 中西部
  • 東北
  • 西南
  • 東南

第8章 競爭格局

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司/競爭對手分類
  • 供應商情況
  • 公司簡介
    • AbbVie, Inc.
    • REVANCE AESTHETICS
    • Merz North America, Inc.
    • Galderma Laboratories, LP
    • Suneva Medical Inc.
    • Cytophil, Inc
    • Prollenium Medical Technologies.
Product Code: GVR-4-68040-284-1

U.S. Facial Injectable Market Growth & Trends:

The U.S. facial injectable market is anticipated to reach USD 8.02 billion by 2030, exhibiting a CAGR of 11.1% from 2024 to 2030, according to a new report by Grand View Research, Inc. The increasing acceptance of aesthetic procedures and the increasing geriatric population are some of the major factors driving the market growth.

The increasing geriatric population of the U.S. is increasing the demand for the development of minimally invasive surgical procedures. Facial injectable offer an alternative to several aesthetic surgical procedures. Moreover, these procedures offer several advantages, such as less pain, less trauma, lesser blood loss, and faster recovery. In addition, the increasing focus of market players on developing demand-specific solutions with lesser allergy risk significantly contributes to the market growth.

The increasing awareness about aesthetic procedures owing to the rising focus on facial appearance further drives the market growth. Moreover, the availability of facial injectable to address different demands of patients has increased their demand in different age groups as per their needs. For instance, according to the 2022 Plastic Surgery Statistics Report of The American Society of Plastic Surgeons, the number of neuromodulator injection procedures in the age group of 30 to 39 and 40 to 54 in 2022 has increased by 70% and 74% from 2019 simultaneously. Similarly, the number of HA filler procedures in the age group of 30 to 39 and 40 to 54 in 2022 has increased by 69% and 70% from 2019 simultaneously. This increasing demand for facial injectable in different age groups is expected to drive market growth over the forecast period.

U.S. Facial Injectable Market Report Highlights:

  • Botulinum toxin type A dominated the product segment with a share of over 55% share in 2023 owing to its wide treatment, such as wrinkles, glabellar lines, lateral canthus, and others.
  • The HA segment is expected to witness the fastest growth over the forecast period owing to the increasing focus of market players on developing hyaluronic fillers. The increasing demand for minimally invasive procedures and the surge in aesthetic procedures are driving the market growth.
  • Some of the market players operating in the U.S. facial injectable market include AbbVie, Inc., REVANCE AESTHETICS, Merz North America, Inc., Galderma Laboratories, L.P., Suneva Medical Inc., Cytophil, Inc, and Prollenium Medical Technologies.
  • In May 2023, Evolus, Inc. announced that the company had entered into an agreement with Symatese to be the distributor of five under-development derma fillers. This step significantly helped the company in expanding its product portfolio and taking a step towards becoming a multi-product aesthetic company.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Application
    • 1.2.3. End-use
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Application outlook
    • 2.2.3. End-use outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Facial Injectable Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing geriatric population
      • 3.2.1.2. Rising awareness of aesthetic procedures
      • 3.2.1.3. Increasing availability of innovative products
      • 3.2.1.4. Rise in the number of aesthetic procedures performed
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Threat of side effects
  • 3.3. U.S. Facial Injectable Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's Five Forces
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. U.S. Facial Injectable Market: Product Estimates & Trend Analysis

  • 4.1. Product Market Share, 2023 & 2030
  • 4.2. Segment Dashboard
  • 4.3. U.S. Facial Injectable Market by Product Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.4.1. Collagen & PMMA microspheres
      • 4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2. Botulinum toxin type A
      • 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.3. HA
      • 4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.4. CaHA
      • 4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.5. PLLA
      • 4.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.6. Others
      • 4.4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. U.S. Facial Injectable Market: Application Estimates & Trend Analysis

  • 5.1. Application Market Share, 2023 & 2030
  • 5.2. Segment Dashboard
  • 5.3. U.S. Facial Injectable Market by Application Outlook
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.4.1. Facial line correction
      • 5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.2. Lip augmentation
      • 5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.3. Face lift
      • 5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.4. Acne scar treatment
      • 5.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.5. Lipoatrophy treatment
      • 5.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.6. Others
      • 5.4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. U.S. Facial Injectable Market: End-use Estimates & Trend Analysis

  • 6.1. End-use Market Share, 2023 & 2030
  • 6.2. Segment Dashboard
  • 6.3. U.S. Facial Injectable Market by End-use Outlook
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 6.4.1. MedSpa
      • 6.4.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
    • 6.4.2. Dermatology clinics
      • 6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.3. Hospitals
      • 6.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. U.S. Facial Injectable Market: Region Estimates & Trend Analysis

  • 7.1. Regional Market Share, 2023 & 2030
  • 7.2. U.S. Facial Injectable Market by Region Outlook
  • 7.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
    • 7.3.1. West
      • 7.3.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
    • 7.3.2. Midwest
      • 7.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.3.3. Northeast
      • 7.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.3.4. Southwest
      • 7.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.3.5. Southeast
      • 7.3.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
  • 8.3. Vendor Landscape
    • 8.3.1. List of key distributors and channel partners
    • 8.3.2. Key customers
    • 8.3.3. Key company heat map analysis, 2023
  • 8.4. Company Profiles
    • 8.4.1. AbbVie, Inc.
      • 8.4.1.1. Company overview
      • 8.4.1.2. Financial performance
      • 8.4.1.3. Product benchmarking
      • 8.4.1.4. Strategic initiatives
    • 8.4.2. REVANCE AESTHETICS
      • 8.4.2.1. Company overview
      • 8.4.2.2. Financial performance
      • 8.4.2.3. Product benchmarking
      • 8.4.2.4. Strategic initiatives
    • 8.4.3. Merz North America, Inc.
      • 8.4.3.1. Company overview
      • 8.4.3.2. Financial performance
      • 8.4.3.3. Product benchmarking
      • 8.4.3.4. Strategic initiatives
    • 8.4.4. Galderma Laboratories, L.P.
      • 8.4.4.1. Company overview
      • 8.4.4.2. Financial performance
      • 8.4.4.3. Product benchmarking
      • 8.4.4.4. Strategic initiatives
    • 8.4.5. Suneva Medical Inc.
      • 8.4.5.1. Company overview
      • 8.4.5.2. Financial performance
      • 8.4.5.3. Product benchmarking
      • 8.4.5.4. Strategic initiatives
    • 8.4.6. Cytophil, Inc
      • 8.4.6.1. Company overview
      • 8.4.6.2. Financial performance
      • 8.4.6.3. Product benchmarking
      • 8.4.6.4. Strategic initiatives
    • 8.4.7. Prollenium Medical Technologies.
      • 8.4.7.1. Company overview
      • 8.4.7.2. Financial performance
      • 8.4.7.3. Product benchmarking
      • 8.4.7.4. Strategic initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 U.S. facial injectable market, by product, 2018 - 2030 (USD Million)
  • Table 4 U.S. facial injectable market, by application, 2018 - 2030 (USD Million)
  • Table 5 U.S. facial injectable market, by end-use, 2018 - 2030 (USD Million)
  • Table 6 U.S. facial injectable market, by region, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 U.S. facial injectable market: market outlook
  • Fig. 9 U.S. facial injectable competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 U.S. facial injectable market driver impact
  • Fig. 14 U.S. facial injectable market restraint impact
  • Fig. 15 U.S. facial injectable market: Product movement analysis
  • Fig. 16 U.S. facial injectable market: Product outlook and key takeaways
  • Fig. 17 Collagen & PMMA microspheres market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 18 Botulinum toxin type A market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 19 HA market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 CaHA market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 PLLA market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 U.S. facial injectable market: Application movement Analysis
  • Fig. 24 U.S. facial injectable market: Application outlook and key takeaways
  • Fig. 25 Facial line correction market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Lip augmentation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Face lift market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Acne scar treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Lipoatrophy treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 U.S. facial injectable market: End-use movement analysis
  • Fig. 32 U.S. facial injectable market: End-use outlook and key takeaways
  • Fig. 33 MedSpa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Dermatology clinics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Hospitals market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 U.S. facial injectable market: Regional movement analysis
  • Fig. 37 U.S. facial injectable market: Regional outlook and key takeaways
  • Fig. 38 West market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Midwest market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Northeast market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Southwest market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Southeast market estimates and forecasts, 2018 - 2030 (USD Million)